Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Annals of Hematology|April 5, 2017
Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomasB Tessoulin, P Thomare, E Delande, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 2, 2008
[Value of basic and intensive management of patients with heart failure; results of a randomised controlled clinical trial]T Jaarsma, M H L van der Wal, I Lesman-Leegte, et al.
The American Journal of Cardiology|April 3, 2018
Comparison of Outcomes and Intervention Among Patients With Non-ST-Segment Elevation Acute Myocardial Infarction of Those With a Left Circumflex Versus Those With a Non-Left Circumflex-Related Coronary Artery (From the ELISA-3 Trial)Erik A Badings, Renicus S Hermanides, Salem H K The, et al.
Archives of Internal Medicine|February 13, 2008
Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH)Tiny Jaarsma, Martje H L van der Wal, Ivonne Lesman-Leegte, et al.
The American Journal of Cardiology|March 27, 2012
Social burden and lifestyle in adults with congenital heart diseaseA Carla Zomer, Ilonca Vaartjes, Cuno S P Uiterwaal, et al.
Tijdschrift Voor Psychiatrie|July 3, 2025
[ECT in patients with deep brain stimulation: The first cases in the Netherlands]G J J Mol, T Goedemans, S Rutten, et al.
Journal of the American College of Cardiology|December 15, 2010
Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) studyLuc W M Eurlings, Petra E J van Pol, Wouter E Kok, et al.
Heart (British Cardiac Society)|July 2, 2013
Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trialHarald T Jorstad, Clemens von Birgelen, A Marco W Alings, et al.
European Journal of Heart Failure|August 30, 2024
Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trialDirk J van Veldhuisen, Michiel Rienstra, Arend Mosterd, et al.
Journal of Cardiac Failure|July 5, 2016
What Are Effective Program Characteristics of Self-Management Interventions in Patients With Heart Failure? An Individual Patient Data Meta-analysisNini H Jonkman, Heleen Westland, Rolf H H Groenwold, et al.
Pageof 7